Most of our research focuses on atopic eczema because the disease is so common, its prevalence is rising, it causes a lot of suffering, and we understand little about its causes, treatment and prevention.
Our other diseases of interest include non-melanoma skin cancer, vitiligo, acne, cellulitis, and rare skin disorders. The three main areas of our activities are systematic reviews, clinical trials and dissemination & implementation.
The research strategy of CEBD is very simple 'To do really good research'. We aim to do this by:
Collaborating with the best people who bring different skills and perspectives, wherever they are.
Getting the right staff structures in place to support development and conduct of research.
Maintaining focus on being world leaders in just a few research areas (disease topics include eczema, vitiligo and non-melanoma skin cancer; methods include systematic reviews, clinical trials and outcome measures).
Engaging with the community who use research to develop new ideas and to measure the impact of our research.
Taking advantage of the funding landscape: being in the right place with the right preliminary data at the right time.
Ensuring that research findings are disseminated credibly and accurately to funders, health care professionals and the wider community.
Conducting research that really matters to people - research that you would be proud of telling a member of the public about.
What are we doing about treatment and prevention of skin disease?
We publish all resources that contribute to patient care in a freely accessible format. Access our resources and tools for clinicians, researchers, patients and carers.
Publications in leading peer-reviewed journals
Our research findings have been published by peer-leading journals such as the New England Journal of Medicine and the British Journal of Dermatology. See our list of books and publications.
The majority of our research is funded through the National Institute for Health Research (NIHR) or medical charities. We are currently in receipt of a prestigious 5-year Programme Grant for Applied Research grant and several large NIHR awards for multi-centre randomised controlled clinical trials.
Through our research we have also been able to influence patient care in various ways including setting priorities for future research and informing guideline and clinical care pathways. (Read more about our impact on patient care.)
Networks and Collaborations
The Cochrane Skin Group is a network of people from all over the world committed to producing and updating systematic reviews of trials relating to skin conditions. Its editorial base is located at the Centre of Evidence Based Dermatology where its output regularly informs other strands of work such as the need for new trials and the best design of new trials. The scope of the Skin Group is wide, and includes any skin problem that leads an individual to seek help from a health care provider. The Group also considers evidence about skin treatments that are sold over-the-counter or are widely available.
Harmonizing Outcome Measures for Eczema (HOME)
The Harmonizing Outcome Measures for Eczema (HOME) initiative was founded in 2008 by Hywel Williams (UK) and Jochen Schmitt (Germany) in response to the use of multiple unvalidated outcome measures in eczema trials. HOME aims to agree a set of core outcome measures for atopic eczema which should be included in ALL clinical trials and clinical record-keeping to allow comparison of data across multiple trials.
UK DCTN - UK Dermatology Clinical Trials Network
The UK Dermatology Clinical Trials Network (UKDCTN) is a dermatology clinical trials network open to anyone with an interest in applied dermatological research. The Network was developed in 2002 by Professor Hywel Williams and a group of academic and clinical colleagues in response to the growing need for high quality evidence to inform dermatology clinical practice. The UK DCTN has now developed into a collaborative, national network of dermatologists, nurses, health service researchers and patient representatives.
IFDCTN - International Federation of Dermatology Clinical Trials Network
Society for Academic Primary Care Special Interest Group for Dermatology